Innovation
6 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 348 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 4 |
Social engagement
Social engagement: 7.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Starquest Capital, Pays de la Loire Participations.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Private equity | 1 | 14% |
| Accelerator & incubator | 1 | 14% |
| Other / undisclosed | 2 | 29% |
Recent activity
12 Mar 2026
Event
GEN webinar on anticorps bispécifiques : relever le défi industriel de la purification
25 Feb 2026
Milestone
anniversary
20 Feb 2026
Milestone
regulatory